Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Director departure
Blue Water Biotech, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
10/10/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Employment Agreement, between the Company and Dr. Neil Campbell",
"Employment Agreement, between the Company and Bruce Harmon",
"Form of Indemnification Agreement",
"General Release of Claims",
"Blue Water Biotech Appoints Dr. Neil J. Campbell as President and CEO and Bruce Harmon as CFO"
10/03/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ...
Docs: "CERTIFICATE OF DESIGNATIONS OF SERIES A PREFERRED STOCK",
"AMENDMENT TO"
08/22/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/10/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Blue Water Biotech and Copay Consultants Collaborate to Build Copay Assistance Programs for Blue Water’ s Commercial Products"
08/03/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ...
Docs: "FORM OF INDUCEMENT PIO",
"FORM OF LETTER AGREEMENT",
"Blue Water Biotech Announces Closing of Warrant Exercise and Issuance of New Warrants in A Private Placement For $2.7 Million Gross Proceeds"
08/01/2023 8-K Quarterly results
07/31/2023 8-K Quarterly results
07/25/2023 8-K Quarterly results
07/21/2023 8-K Quarterly results
07/17/2023 8-K Quarterly results
07/11/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Blue Water Biotech Teams with Advantage Point Solutions to Provide Healthcare Payer Coverage Support"
07/06/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Blue Water Biotech Secures License from Ohio State Board of Pharmacy to Operate as Pharmaceutical Wholesaler for its FDA Approved Products"
07/06/2023 8-K Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits  Interactive Data
Docs: "Letter from Mayer Hoffman McCann P.C."
07/06/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Blue Water Biotech Teams with BFW Advertising to Market and Advertise Commercial Product Portfolio"
06/06/2023 8-K Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of...
Docs: "THIRD AMENDED AND RESTATED BYLAWS OF BLUE WATER BIOTECH, INC"
05/15/2023 8-K Investor presentation
Docs: "PRESENTATION, DATED MAY 2023"
05/10/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Blue Water Biotech to Present Corporate Overview and ENTADFI Launch Plan at the JMP Securities Life Sciences Conference in"
04/24/2023 8-K Quarterly results
04/20/2023 8-K Quarterly results
03/29/2023 8-K Quarterly results
03/13/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "BLUE WATER VACCINES INC."
01/17/2023 8-K Resignation/termination of a director
Docs: "Blue Water Vaccines Announces Appointment of Seasoned Public Market and Private Equity Investment Leader Timothy Ramdeen to Board of Directors"
01/09/2023 8-K Quarterly results
01/06/2023 8-K Quarterly results
12/12/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Blue Water Vaccines Announces Institutional Research Coverage by Two Notable Healthcare-Focused Wall Street Banks, Receives “Buy” Rating From Both"
12/06/2022 8-K Quarterly results
12/01/2022 8-K Quarterly results
11/21/2022 8-K Quarterly results
11/10/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Blue Water Vaccines Reports Third Quarter 2022 Financial Results and Recent Business Highlights; Announces 5 Million Share Repurchase Program"
11/08/2022 8-K Quarterly results
10/12/2022 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "PRESENTATION, DATED OCTOBER 13, 2022"
10/11/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Blue Water Vaccines Announces Plans to Evaluate Efficacy of Streptococcus pneumoniae Vaccine Candidate Against Pneumococcal Pneumonia at the World Vaccine Congress in Barcelona"
09/12/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "CORPORATE PRESENTATION, AS OF SEPTEMBER 2022"
08/22/2022 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy